OBJECTIVE: To determine whether dexamethasone use increases the risk for Candida sepsis (CS) in very low birth weight premature infants (<1250 g). DESIGN: Retrospective chart review of all infants with a birth weight <1250 g, admitted to the neonatal intensive care unit of the MetroHealth Medical Center, Cleveland, Ohio between January 1, 1996 and December 31, 1999. Infant groups with (n=65) and without (n=229) CS were compared. RESULTS: Two hundred and ninety four infants with a birth weight <1250 g were identified. CS was diagnosed at a median age of 18 days, and 6 of 65 (10%) infants died directly from Candida-related complications. Candida albicans (n=30, 60%) and Candida parapsilosis (n=14, 25%) were the predominant isolates. Use of dexamethasone in infants at risk for chronic lung disease before 14 days of age (p=0.001), duration of antibiotics (p=0.001), and total duration of parenteral nutrition and intralipid (p=0.0001) were all significantly greater in infants who developed CS. Regression analysis showed that duration of antibiotics before the diagnosis of Candida infection (r(2)=0.69, p=0.0002) and duration of dexamethasone (r(2)=0.93, p=0.0002) correlated with Candida infection. Early dexamethasone use was also related to the age at diagnosis of Candida infection (r(2)=0.51, p=0.01). CONCLUSIONS: Dexamethasone therapy and prolonged duration of antibiotics are associated with Candida infection in premature infants.
OBJECTIVE: To determine whether dexamethasone use increases the risk for Candida sepsis (CS) in very low birth weight premature infants (<1250 g). DESIGN: Retrospective chart review of all infants with a birth weight <1250 g, admitted to the neonatal intensive care unit of the MetroHealth Medical Center, Cleveland, Ohio between January 1, 1996 and December 31, 1999. Infant groups with (n=65) and without (n=229) CS were compared. RESULTS: Two hundred and ninety four infants with a birth weight <1250 g were identified. CS was diagnosed at a median age of 18 days, and 6 of 65 (10%) infants died directly from Candida-related complications. Candida albicans (n=30, 60%) and Candida parapsilosis (n=14, 25%) were the predominant isolates. Use of dexamethasone in infants at risk for chronic lung disease before 14 days of age (p=0.001), duration of antibiotics (p=0.001), and total duration of parenteral nutrition and intralipid (p=0.0001) were all significantly greater in infants who developed CS. Regression analysis showed that duration of antibiotics before the diagnosis of Candida infection (r(2)=0.69, p=0.0002) and duration of dexamethasone (r(2)=0.93, p=0.0002) correlated with Candida infection. Early dexamethasone use was also related to the age at diagnosis of Candida infection (r(2)=0.51, p=0.01). CONCLUSIONS:Dexamethasone therapy and prolonged duration of antibiotics are associated with Candida infection in premature infants.
Authors: D K Meyerholz; B Grubor; T Lazic; J M Gallup; M M A de Macedo; P B McCray; M R Ackermann Journal: Vet Pathol Date: 2006-09 Impact factor: 2.221
Authors: Simonetta Frezza; Luca Maggio; Maria Pia De Carolis; Francesca Gallini; Maria Puopolo; Valentina Polimeni; Simonetta Costa; Giovanni Vento; Giuseppe Tortorolo Journal: Eur J Pediatr Date: 2004-11-13 Impact factor: 3.183
Authors: Nicolas Millet; Norma V Solis; Diane Aguilar; Michail S Lionakis; Robert T Wheeler; Nicholas Jendzjowsky; Marc Swidergall Journal: Nat Commun Date: 2022-09-22 Impact factor: 17.694
Authors: Sofia Aliaga; Reese H Clark; Matthew Laughon; Thomas J Walsh; William W Hope; Daniel K Benjamin; David Kaufman; Antonio Arrieta; Daniel K Benjamin; P Brian Smith Journal: Pediatrics Date: 2014-01-20 Impact factor: 9.703